Published in J Acquir Immune Defic Syndr on January 01, 1990
Is frequent CD4+ T-lymphocyte count monitoring necessary for persons with counts >=300 cells/μL and HIV-1 suppression? Clin Infect Dis (2013) 3.82
Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest (1999) 2.48
Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44
Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol (1992) 2.27
The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol (1992) 1.98
Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med (1996) 1.82
Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS (2012) 1.35
The impact of monitoring HIV patients prior to treatment in resource-poor settings: insights from mathematical modelling. PLoS Med (2008) 1.32
Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection--a quantitative review. PLoS One (2009) 1.31
Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One (2008) 1.27
Immunohaematological reference values in human immunodeficiency virus-negative adolescent and adults in rural northern Tanzania. BMC Infect Dis (2009) 1.22
Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol (2004) 1.20
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials. PLoS One (2008) 1.15
Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin Vaccine Immunol (2008) 1.13
Delay of antiretroviral therapy initiation is common in East African HIV-infected individuals in serodiscordant partnerships. J Acquir Immune Defic Syndr (2014) 1.09
Determination of CD4 and CD8 lymphocyte subsets by a new alternative fluorescence immunoassay. Clin Diagn Lab Immunol (1995) 1.09
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Clinical data sets of human immunodeficiency virus type 1 reverse transcriptase-resistant mutants explained by a mathematical model. J Virol (1997) 1.07
Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients. Clin Diagn Lab Immunol (2005) 1.04
Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects. Antimicrob Agents Chemother (2007) 1.00
When should asymptomatic patients with HIV infection be treated with zidovudine? BMJ (1992) 0.97
A review on peripheral blood CD4+ T lymphocyte counts in healthy adult Indians. Indian J Med Res (2010) 0.97
Immunohaematological reference values for HIV-negative healthy adults in Botswana. Afr J Lab Med (2012) 0.95
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals. AIDS (2014) 0.94
Current practices in laboratory monitoring of HIV infection. Indian J Med Res (2011) 0.94
Predicting AIDS-related events using CD4 percentage or CD4 absolute counts. AIDS Res Ther (2006) 0.87
Measurement of induced cytokines in AIDS clinical trials using whole blood: a preliminary report. ACTG Inducible Cytokines Focus Group. AIDS Clinical Trials Group. Clin Diagn Lab Immunol (1998) 0.86
Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression. PLoS One (2014) 0.80
Simultaneous Treatment of Missing Data and Measurement Error in HIV Research Using Multiple Overimputation. Epidemiology (2015) 0.80
Normal Range of CD4 Cell Counts and Temporal Changes in Two HIVNegative Malawian Populations. Open AIDS J (2011) 0.79
Quantitative Assessment of Intra-Patient Variation in CD4+ T Cell Counts in Stable, Virologically-Suppressed, HIV-Infected Subjects. PLoS One (2015) 0.76
T cell subset profile in healthy Zambian adults at the University Teaching Hospital. Pan Afr Med J (2016) 0.75
Derivation and validation of an accurate estimation of CD4 counts from the absolute lymphocyte count in virologically suppressed and immunologically reconstituted HIV infected adults. BMC Infect Dis (2015) 0.75
Simple markers for the detection of severe immunosuppression in children with HIV infection in highly resource-scarce settings: experience from the Democratic Republic of Congo. Pathog Glob Health (2015) 0.75
CD4 Cell Count: Declining Value for Antiretroviral Therapy Eligibility. Clin Infect Dis (2016) 0.75
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med (1988) 9.21
Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med (1977) 8.24
Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses (1995) 7.12
Causes of the acute urethral syndrome in women. N Engl J Med (1980) 6.91
Effect of temperature on the vector efficiency of Aedes aegypti for dengue 2 virus. Am J Trop Med Hyg (1987) 5.53
Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg (1989) 4.79
Etiology of interepidemic periods of mosquito-borne disease. Proc Natl Acad Sci U S A (2000) 4.75
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am J Trop Med Hyg (1988) 4.65
Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis (1977) 3.51
Antibody capture immunoassay detection of japanese encephalitis virus immunoglobulin m and g antibodies in cerebrospinal fluid. J Clin Microbiol (1982) 3.44
Detection of diverse HIV-1 genetic subtypes in the USA. Lancet (1995) 3.41
Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol (1996) 2.83
Human immunodeficiency virus infections among civilian applicants for United States military service, October 1985 to March 1986. Demographic factors associated with seropositivity. N Engl J Med (1987) 2.81
Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med (1987) 2.59
Kinetics of IgM and IgG responses to Japanese encephalitis virus in human serum and cerebrospinal fluid. J Infect Dis (1985) 2.59
Genetic variants of HIV-1 in Thailand. AIDS Res Hum Retroviruses (1992) 2.52
Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol (1995) 2.48
Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis (1994) 2.42
Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology (1995) 2.38
Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science (1988) 2.31
Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science (1996) 2.11
Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay. J Clin Microbiol (1982) 2.10
False-positive Western blot tests for antibodies to HTLV-III. JAMA (1986) 2.07
Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies. Am J Trop Med Hyg (1985) 2.04
The risk of birth defects among children of Persian Gulf War veterans. N Engl J Med (1997) 2.02
Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med (1979) 1.94
Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses (1996) 1.92
Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes. AIDS Res Hum Retroviruses (1994) 1.90
Direct measurement of human immunodeficiency virus seroconversions in a serially tested population of young adults in the United States Army, October 1985 to October 1987. Walter Reed Retrovirus Research Group. N Engl J Med (1989) 1.89
Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet (1983) 1.80
Specific immunoglobulin M response to hepatitis A virus determined by solid-phase radioimmunoassay. Infect Immun (1980) 1.79
Evaluation of pertussis in U.S. Marine Corps trainees. Clin Infect Dis (1997) 1.79
Japanese encephalitis: immunocytochemical studies of viral antigen and inflammatory cells in fatal cases. Ann Neurol (1985) 1.73
HIV-1 genetic diversity. AIDS (1996) 1.69
Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA (1993) 1.63
The endemic infectious diseases of Somalia. Clin Infect Dis (1993) 1.62
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial. Ann Intern Med (1980) 1.61
Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA (1987) 1.59
Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein. J Gen Virol (1989) 1.59
Prediction of relapse after treatment of coccidioidomycosis. Clin Infect Dis (1997) 1.58
Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg (1989) 1.57
Evidence of previous avian influenza infection among US turkey workers. Zoonoses Public Health (2009) 1.56
Molluscum contagiosum. Ultrastructural evidence for its presence in skin adjacent to clinical lesions in patients infected with human immunodeficiency virus type 1. Military Medical Consortium for Applied Retroviral Research. Arch Dermatol (1992) 1.54
Prevalence and incidence of HTLV-III infection in a prison. JAMA (1986) 1.48
Induction of human immunodeficiency virus type 1 expression in chronically infected cells is associated primarily with a shift in RNA splicing patterns. J Virol (1991) 1.48
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res Hum Retroviruses (1996) 1.46
Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (VEE) virus after immunization with attenuated (TC-83) VEE virus vaccine. J Infect Dis (1977) 1.44
Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin. Clin Microbiol Infect (2000) 1.43
Concurrent HPV-16 infection of the nipple and perianal area in an HIV-1+ patient. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR) Int J Dermatol (1993) 1.43
Hospitalizations for unexplained illnesses among U.S. veterans of the Persian Gulf War. Emerg Infect Dis (1998) 1.42
The current distribution of CD4+ T-lymphocyte counts among adults in the United States with human immunodeficiency virus infections: estimates based on the experience of the U.S. Army. U.S. Army Retrovirus Research Group. J Acquir Immune Defic Syndr (1990) 1.42
Exaggerated insect bite reactions in patients positive for HIV. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol (1993) 1.39
Lack of induction of antibodies specific for conserved, discontinuous epitopes of HIV-1 envelope glycoprotein by candidate AIDS vaccines. J Immunol (1995) 1.37
Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proc Natl Acad Sci U S A (1991) 1.37
Virulence of a live dengue virus vaccine candidate: a possible new marker of dengue virus attenuation. J Infect Dis (1988) 1.37
Large, persistent epidemic of adenovirus type 4-associated acute respiratory disease in U.S. army trainees. Emerg Infect Dis (2000) 1.33
Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus. J Clin Microbiol (1987) 1.33
Induction of interleukin-6 during human immunodeficiency virus infection. Blood (1990) 1.32
Goldenhar syndrome among infants born in military hospitals to Gulf War veterans. Teratology (1997) 1.32
Factor analysis of self-reported symptoms: does it identify a Gulf War syndrome? Am J Epidemiol (2000) 1.32
Diagnosis of human immunodeficiency virus infection by immunoassay using a molecularly cloned and expressed virus envelope polypeptide. Comparison to Western blot on 2707 consecutive serum samples. Ann Intern Med (1987) 1.32
Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection. Vaccine (1993) 1.32
Fatal outcome in Japanese encephalitis. Am J Trop Med Hyg (1985) 1.30
Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort. J Virol (1995) 1.30
Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol (1997) 1.30
Human immunodeficiency virus seropositivity among members of the active duty US Army 1985-89. Am J Public Health (1990) 1.26
HIV infection: the clinical picture. Sci Am (1988) 1.24
Outbreak of influenza in highly vaccinated crew of U.S. Navy ship. Emerg Infect Dis (2001) 1.23
Simplified microneutralization test for serotyping adenovirus isolates. J Clin Microbiol (2001) 1.22
Patterns of virus burden and T cell phenotype are established early and are correlated with the rate of disease progression in human immunodeficiency virus type 1-infected persons. J Infect Dis (1996) 1.22
Febrile illness in Malaysia--an analysis of 1,629 hospitalized patients. Am J Trop Med Hyg (1984) 1.21
Dengue virus type 2 vaccine: reactogenicity and immunogenicity in soldiers. J Infect Dis (1984) 1.20
The AG recombinant IbNG and novel strains of group M HIV-1 are common in Cameroon. Virology (2001) 1.20
Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. J Immunol (1990) 1.18
Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr (1992) 1.16
Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J Virol (1997) 1.14
Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol (1996) 1.14
Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research (MMCARR). J Am Acad Dermatol (1994) 1.13
The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health (1993) 1.11
Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin Infect Dis (1998) 1.10
Cardiac risk factors and complications in non-cardiac surgery. Medicine (Baltimore) (1978) 1.10
Geographic classification of dengue-2 virus strains by antigen signature analysis. Virology (1986) 1.08
Frequent isolation of HIV-1 from the blood of patients receiving zidovudine (AZT) therapy. N Engl J Med (1989) 1.08
Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: a comparison by site and correlation with clinical information. J Infect Dis (1997) 1.07
Correlates of HIV-1 seropositivity among young men in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 1.07
Clinical manifestations of Kingella kingae infections: case report and review. Rev Infect Dis (1989) 1.07
Field trial of a Japanese encephalitis diagnostic kit. J Med Virol (1986) 1.05
A human immunodeficiency virus type 1 (HIV-1)-based retroviral vector system utilizing stable HIV-1 packaging cell lines. J Virol (1994) 1.05
Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses (1993) 1.05
Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission. N Engl J Med (1977) 1.04
False-positive direct fluorescent antibody testing for Legionella. JAMA (1985) 1.04
Human immunodeficiency virus type-1 seroconversion trends among young adults serving in the United States Army, 1985-1993. United States Military Medical Consortium for Applied Retroviral Research. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.04
Birth defects prevalence among infants of Persian Gulf War veterans born in Hawaii, 1989-1993. Teratology (2000) 1.03
Prevalence, antibiotic resistance and molecular characterisation of Staphylococcus aureus in pigs at agricultural fairs in the USA. Vet Rec (2012) 1.02